In this case report, we highlight the adverse effects of ECT in a patient with autism spectrum disorder that was subsequently found to have a de novo pathogenic CACNA1a variant that is known to be associated with hemiplegic migraines. The gene discussed is CACNA1A; the disease is autism spectrum disorder.